TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia.
Saved in:
| Title: | TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia. |
|---|---|
| Authors: | Dreisig, Karin1 (AUTHOR), Brünner, Emilie Damgaard1 (AUTHOR), Marquart, Hanne V.2 (AUTHOR), Helt, Louise Rold1 (AUTHOR), Nersting, Jacob1 (AUTHOR), Frandsen, Thomas Leth3 (AUTHOR), Jonsson, Olafur Gisli4 (AUTHOR), Taskinen, Mervi5 (AUTHOR), Vaitkeviciene, Goda6 (AUTHOR), Lund, Bendik7 (AUTHOR), Abrahamsson, Jonas8 (AUTHOR), Lepik, Kristi9 (AUTHOR), Schmiegelow, Kjeld1,3,10 (AUTHOR) |
| Source: | Pediatric Hematology & Oncology. Apr2021, Vol. 38 Issue 3, p227-238. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
